Bassiouni Hischam, Asgari Siamak, Sandalcioglu I Erol, Seifert Volker, Stolke Dietmar, Marquardt Gerhard
Department of Neurosurgery, University Hospital Essen, Germany.
J Neurosurg. 2009 Nov;111(5):1078-90. doi: 10.3171/2009.3.17685.
In this study, the authors' goal was to analyze a series of patients treated microsurgically for an anterior clinoid process (ACP) meningioma in regard to long-term functional outcome.
The authors retrospectively analyzed clinical data in a consecutive series of 106 patients who underwent microsurgical treatment for an ACP meningioma at 2 neurosurgical institutions between 1987 and 2005. The main presenting symptoms of the 84 female and 22 male patients (mean age 56 years) were visual impairment in 54% and headache in 28%. Physical examination revealed decreased visual acuity in 49% and a visual field deficit in 26%. Tumors were primarily resected via a pterional approach. Meningioma extensions invading the cavernous sinus, present in 29% of the patients, were not removed. Complete tumor resection (Simpson Grade I and II) was achieved in 59% of the cases.
Postoperatively, visual acuity improved in 40%, was unchanged in 46%, and deteriorated in 14%. A new oculomotor palsy was observed in 8 patients (8%). Clinical and MR imaging data were available in 95 patients for a mean postsurgical period of 6.9 years (1.5-18 years) and revealed tumor recurrence in 10% and tumor progression after subtotal resection in 38%. Clinical deterioration on long-term follow-up consisting primarily of ophthalmological deficits was observed in 14% of the cases.
Acceptable functional results can be achieved after microsurgical resection of ACP meningiomas; however, long-term treatment remains challenging due to a high tumor recurrence and progression rate.
在本研究中,作者的目标是分析一系列接受显微手术治疗前床突(ACP)脑膜瘤患者的长期功能结局。
作者回顾性分析了1987年至2005年间在2家神经外科机构接受显微手术治疗ACP脑膜瘤的106例连续患者的临床资料。84例女性和22例男性患者(平均年龄56岁)的主要症状为视力障碍(54%)和头痛(28%)。体格检查发现49%的患者视力下降,26%的患者有视野缺损。肿瘤主要通过翼点入路进行切除。29%的患者存在侵犯海绵窦的脑膜瘤延伸部分,未予切除。59%的病例实现了肿瘤全切(辛普森一级和二级)。
术后,40%的患者视力改善,46%的患者视力无变化,14%的患者视力恶化。8例患者(8%)出现新的动眼神经麻痹。95例患者可获得临床和磁共振成像数据,术后平均随访期为6.9年(1.5 - 18年),结果显示10%的患者肿瘤复发,次全切除术后38%的患者肿瘤进展。14%的病例在长期随访中出现主要由眼科缺陷导致的临床恶化。
显微手术切除ACP脑膜瘤后可获得可接受 的功能结果;然而,由于肿瘤复发和进展率高,长期治疗仍然具有挑战性。